The genetic profiles of CYP1A1, CYP1A2 and CYP2E1 enzymes as susceptibility factor in xenobiotic toxicity in Turkish population.
Evaluation and sequencing of heritable alterations in the human genome and the large-scale identification of gene polymorphism for understanding the genetic background of individuals in response to potential toxicants are provided by toxicogenetics. Cytochrome P450 (CYP) enzymes play role not only phase I-dependent metabolism of xenobiotics but also metabolism of endogenous compounds. CYP1A1, CYP1A2 and CYP2E1 enzymes, which are in phase I enzymes, are responsible for metabolic activation and detoxification of several chemical compounds. In the present study, it was determined the genotype and allele frequency ofCYP1A1∗2A, CYP1A2∗1C, CYP1A2∗1F,CYP2E1andCYP2E1∗6, very common and functional single-nucleotide polymorphisms (SNPs), in Turkish healthy volunteers. It is believed that the determination of polymorphisms in the enzymes may be beneficial to prevent and reduce and adverse effects and death in response to drugs. The allele frequencies of these genes were 24%, 9%, 33%, 42%, and 12%, respectively. In the present study, the genotype profile of Turkish population was determined about critical enzymes for xenobiotic metabolism. It is suggested that the obtained results might be beneficial in order to dose adjustment of drugs and prevention of adverse reactions, and further investigation about mentioned enzymes and their polymorphisms.
Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Beyazıt 34116, Istanbul, Turkey.
Merve
M
Arici
Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Beyazıt 34116, Istanbul, Turkey.
Gül
G
Özhan
CYP1A1; CYP1A2; CYP2E1; Cytochrome P450; Genetic polymorphism; Turkish population